Search Results - "Valats, J."

Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis by Christophorou, D., Funakoshi, N., Duny, Y., Valats, J.‐C., Bismuth, M., Pineton De Chambrun, G., Daures, J.‐P., Blanc, P.

“…Summary Background The benefit of the combination of infliximab (IFX) and immunosuppressant (IS) therapy is debated in ulcerative colitis (UC). Aims To…”
Get full text

Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination by Valats, J.C, Tuaillon, E, Funakoshi, N, Hoa, D, Brabet, M.C, Bolloré, K, Ducos, J, Vendrell, J.P, Blanc, P

“…Abstract Up to 20% of health care workers are considered as non-responders to hepatitis B vaccination (anti-HBs < 10 mUI/ml in serum). We have explored memory…”
Get full text

Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis by Henry, L, Lavabre-Bertrand, T, Vercambre, L, Ramos, J, Carillo, S, Guiraud, I, Pouderoux, P, Bismuth, M, Valats, J-C, Demattei, C, Duny, Y, Chaze, I, Funakoshi, N, Bureau, J P, Daurès, J-P, Blanc, P

“…Proteasomes are the main non-lysosomal proteolytic structures which regulate crucial cellular processes. Circulating proteasome levels can be measured using an…”
Get more information

OC.05.1 A CONTROLLED, RANDOMIZED CLINICAL TRIAL ON MANNITOL VERSUS PEG-ASC FOR BOWEL PREPARATION: EFFICACY AND SAFETY RESULTS FROM SATISFACTION STUDY by Vecchi, M., Tontini, G.E., Fiori, G., Bocus, P., Cannizzaro, R., Carnovali, M., Cesana, B., Cesaro, P., Costamagna, G., Di Paolo, D., Elli, L., Fedorishina, O., Hinkel, C., Jakobs, R., Kashin, S., Manes, G., Melnikova, E., Orsatti, A., Ponchon, T., Prada, A., Radaelli, F., Rimondi, A., Sferrazza, S., Soru, P., Testoni, P., Valats, J., Veselov, V., Spada, C., Uebel, P.

Get full text

P770 Epidemiology of inflammatory bowel diseases in French Polynesia by Grymonpré, V, Loria, A, Beaugendre, E, Condat, B, Tassy, B, Bouta, N, Bismuth, M, Panaro, F, Valats, J-C, Blanc, P, Pineton de Chambrun, G

“…Abstract Background The prevalence of inflammatory bowel diseases (IBD) in Southeast Asia has been rapidly growing over the last 50 years. French Polynesia is…”
Get full text

P358 Efficacy of golimumab for the treatment of ulcerative colitis patients in clinical practice: a retrospective cohort study by Dufour, G., Altwegg, R., Valats, J.-C., Bismuth, M., Funakoshi, N., Gonzalez, F., Caillo, L., Pouderoux, P., Blanc, P., Pineton de Chambrun, G.

Get full text

P442 Infliximab versus combination infliximab and immunosuppressant therapy for patients with active ulcerative colitis: a meta-analysis by Christophorou, D., Funakoshi, N., Duny, Y., Valats, J.-C., Bismuth, M., Daures, J.-P., Blanc, P.

Get full text

Syndrome de Budd-Chiari secondaire à une sarcoïdose : à propos d’un cas en 2011 au service des maladies de l’appareil digestif du CHU de Montpellier by Bah, A. O., Berete, A., Blanc, P., Pageaux, G. P., Larrey, D., Funakoshi, N., Valats, J. C., Altewegg, R., Bismuth, M., Faure, S., Chambon-Augoyard, C.

“…Résumé Le syndrome de Budd-Chiari compliquant une sarcoïdose hépatique est rare. De nos jours, il n’existe pas d’arguments consensuels pouvant expliquer le…”
Get full text

Innovations techniques by POUSSIER, M, NEDELCU, M, CHOUILLARD, E, CATHELINE, J.-M, NOEL, P, SKALLI, M, DENEVE, E, DOMERGUE, S, VALATS, J.-C, FABRE, J.-M, NOCCA, D, SODJI, M, DARGENT, J

Get full text